Ifosfamide-based chemotherapy yields high survival rate for treatment of osteosarcoma
Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysisDrug Des Devel Ther. 2015 Nov 4;9:5925-32
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Seven randomized controlled trials with 2,529 patients with histologically confirmed osteosarcoma were included in this meta-analysis. The purpose of this study was to compare the safety and efficacy of ifosfamide-based chemotherapy to a control group receiving chemotherapy without ifosfamide. The results displayed that ifosfamide-based chemotherapy had significantly higher event-free survival, ov...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE